Patent · US Expired

Monoclonal antibodies to the human LDL receptor, their production and use

US6849720B2 · kind B2 · utility

1Cited by
1References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 8, 2001
Grant dateFeb 1, 2005
Priority date
Expiry dateMar 8, 2021

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S436/82
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There are provided monoclonal antibodies to the LDL receptor which are useful for the identification and purification of LDL and in treatment of e.g. hepatitis C infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.